Maher Albitar
Overview
Explore the profile of Maher Albitar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
202
Citations
5786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albitar M, Charifa A, Agersborg S, Pecora A, Ip A, Goy A
J Liq Biopsy
. 2025 Mar;
6:100270.
PMID: 40027317
Most of the current utilization of liquid biopsy (LBx) is based on analyzing cell-free DNA(cfDNA). There is limited data on using cell-free RNA (cfRNA) levels (liquid transcriptome) in LBx. The...
2.
Charifa A, Agersborg S, Mohtashamian A, Ip A, Goy A, Albitar M
J Liq Biopsy
. 2025 Mar;
6:100281.
PMID: 40027311
Background: Cytopathology analysis of cerebrospinal fluid (CSF) is limited in detecting tumors in patients with suspected primary or metastatic central nervous system (CNS) malignancy. We investigated the use of CSF...
3.
Ip A, Kabat M, Fogel L, Alkhatatneh H, Voss J, Gupta A, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002289
Advancements in mantle cell lymphoma (MCL) have illuminated the disease's molecular diversity, leading to a wide variation in the outcomes observed in MCL. Current prognostic risk scores are continuously revised...
4.
Rowley S, Albitar M, Baker M, Ali A, Kaur S, Suh H, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002220
: Disease relapse is a primary cause of treatment failure after hematopoietic stem cell transplantation in the treatment of malignancy. Consolidation therapy early after transplantation may reduce this risk, but...
5.
6.
Brochner Pedersen T, Poulsen M, Lund M, Feddersen S, Albitar M, Aaberg Poulsen C, et al.
Scand J Urol
. 2025 Jan;
60():8-13.
PMID: 39807621
Objective: Early and accurate diagnosis of prostate cancer (PC) is crucial for effective treatment. Diagnosing clinically insignificant cancers can lead to overdiagnosis and overtreatment, highlighting the importance of accurately selecting...
7.
Ozdemirli M, Loughney T, Deniz E, Chahine J, Albitar M, Pittaluga S, et al.
N Engl J Med
. 2024 Jun;
390(22):2074-2082.
PMID: 38865661
Indolent CD4+ cytotoxic chimeric antigen receptor (CAR) T-cell lymphoma involving the small intestine was diagnosed in a patient who had previously received ciltacabtagene autoleucel (cilta-cel) CAR T-cell therapy for treatment...
8.
Rowley S, Gunning T, Pelliccia M, Della Pia A, Lee A, Behrmann J, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611035
Acute graft-versus-host disease (aGvHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). We performed RNA analysis of 1408 candidate genes in bone marrow...
9.
Albitar M, Zhang H, Pecora A, Waintraub S, Graham D, Hellmann M, et al.
Breast Cancer (Auckl)
. 2023 Oct;
17:11782234231198979.
PMID: 37789896
Background: Homologous recombination deficiency (HRD) is the hallmark of breast cancer gene 1/2 ()-mutated tumors and the unique biomarker for predicting response to double-strand break (DSB)-inducing drugs. The demonstration of...
10.
Albitar M, Zhang H, Charifa A, Ip A, Ma W, McCloskey J, et al.
Heliyon
. 2023 May;
9(5):e16261.
PMID: 37251903
Current use of liquid biopsy is based on cell-free DNA (cfDNA) and the evaluation of mutations or methylation pattern. However, expressed RNA can capture mutations, changes in expression levels due...